Double hit on melanoma unlocks barrier to immunotherapy

Researchers at EPFL and UNIL have discovered a dangerous liaison between immune cells that limits the efficacy of immunotherapy in melanoma. But they also found a way to disrupt it.

Donation

Help the ISREC Foundation support cancer research

Help us

ISREC Foundation
Rue du Bugnon 25A
CH-1005 Lausanne / Suisse
CCP 10-3224-9
Tel. : +41 (0)21 653 07 16

Contact form